To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. If you experience any issues with your products or services, please contact ATCC Customer Service at sales@atcc.org. For Technical questions please contact tech@atcc.org. Thank you.
X

Privacy Policy Update

We remain dedicated to protecting your data and experience throughout our platforms. We have updated our Privacy Policy and your continued use of the Site means you have accepted the revised Privacy Policy. View now >
X

Epithelial-Mesenchymal Transition Reporter Cell Lines

Epithelial-Mesenchymal Transition Reporter Cell Lines

Epithelial-mesenchymal transition (EMT) describes a cellular process during which differentiated epithelial cells lose their epithelial features and gain mesenchymal properties. EMT has been implicated in the invasion-metastasis cascade hallmark of cancer; cells undergoing EMT display an ability to promote metastasis and elevated drug resistance. Therefore, an in vitro EMT reporter cell model is a valuable tool for dissecting EMT molecular pathways and screening therapeutic compounds. ATCC recently created novel EMT reporter knock-in cell lines by using CRISPR/Cas9 genome-editing technology. These EMT reporter cells faithfully recapitulate the endogenous EMT marker expression; in response to treatment, the reporter cells undergo EMT, enabling real-time monitoring of dynamic EMT intermediate states in live cells. Further, we present application data indicating that pathway- specific inhibitors can block EMT in a dose-dependent manner.